Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review
- PMID: 17596055
Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review
Abstract
Background: Recombinant activated factor VII is used for the treatment in patients with inherited or acquired hemophilia with inhibitors and congenital factor VII deficiencies.
Objective: Using recombinant activated factor VII in primary postpartum hemorrhage.
Material and method: Two cases of women who had postpartum hemorrhage and were treated with recombinant activated factor VII after all conventional treatment failed.
Results: The intractable hemorrhage stopped after treatment with recombinant activated factor VII CONCLUSION: The present report showed that massive postpartum hemorrhage that failed to all procedures was controlled successfully by recombinant activated factor VII.